Mankind Pharma Limited — Credit Ratings, 06-11-2024: Credit Rating

Mankind Pharma Limited announced that CRISIL Ratings has reaffirmed its credit ratings for various instruments. The ratings include a CRISIL A1+ for ₹5,000 crore in commercial paper, and AA+/Stable for ₹4,600 crore and ₹400 crore non-convertible debentures, as well as ₹1,250 crore in total bank loan facilities (long-term rating). For more details, visit the company's website.